Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Antony J, Sabin"'
Publikováno v:
The American Journal of Tropical Medicine and Hygiene. 73:1005-1011
Sitamaquine (WR6026) is an 8-aminoquinoline in development for the oral treatment of visceral leishmaniasis (VL). This was an open-label, dose-increasing study to determine the dose-response and safety profile for sitamaquine in Kenyan patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b5ad98888515a67ad616749c330cad1e
https://doi.org/10.4269/ajtmh.2005.73.1005
https://doi.org/10.4269/ajtmh.2005.73.1005
Autor:
Tara K, Jha, Shyam, Sundar, Chandreshwar P, Thakur, J Mark, Felton, Antony J, Sabin, John, Horton
Publikováno v:
The American journal of tropical medicine and hygiene. 73(6)
This randomized, open label, multicenter study assessed the dose-response and safety profile for oral sitamaquine in 120 Indian subjects with visceral leishmaniasis (VL). Patients aged 5-64 years (mean age 21.2 years) received one of four sitamaquine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5073a0fc7618981b95ea9c4d1ee7d139
https://pubmed.ncbi.nlm.nih.gov/16354802
https://pubmed.ncbi.nlm.nih.gov/16354802
A phase II dose-increasing study of sitamaquine for the treatment of visceral leishmaniasis in Kenya
Autor:
Monique K, Wasunna, Juma R, Rashid, Jane, Mbui, George, Kirigi, Dedan, Kinoti, Hudson, Lodenyo, J Mark, Felton, Antony J, Sabin, M John, Albert, John, Horton
Publikováno v:
The American journal of tropical medicine and hygiene. 73(5)
Sitamaquine (WR6026) is an 8-aminoquinoline in development for the oral treatment of visceral leishmaniasis (VL). This was an open-label, dose-increasing study to determine the dose-response and safety profile for sitamaquine in Kenyan patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::48119b898dad4d3d284c3032390238a7
https://pubmed.ncbi.nlm.nih.gov/16282296
https://pubmed.ncbi.nlm.nih.gov/16282296